Efficacy and safety of everolimus treatment in a hemodialysis patient with metastatic atypical bronchial carcinoid: case report and literature review

Abstract Background Everolimus was recently approved for the treatment of neuroendocrine tumors. However, its efficacy and tolerability in hemodialysis patients with end-stage renal disease is not established. Case presentation We describe the case of a 47-year-old man with end-stage renal disease w...

Full description

Bibliographic Details
Main Authors: M. P. Brizzi, A. La Salvia, M. Tampellini, C. Sonetto, M. Volante, G. V. Scagliotti
Format: Article
Language:English
Published: BMC 2018-03-01
Series:BMC Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12885-018-4205-0